Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ausems

Showing results (161-170 of 204) with videos related to

Pageof 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2023
High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of <i>BRCA1/2</i> Pathogenic Variants: Prevalence and Clinical FactorsIris A S Stroot, Jan Brouwer, Joost Bart, et al.
Journal of Medical Genetics|September 6, 2005
Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP)M Nielsen, P F Franken, T H C M Reinards, et al.
British Journal of Cancer|January 16, 2014
Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trialM R Wevers, N K Aaronson, S Verhoef, et al.
International Journal of Cancer|October 13, 2025
Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathwayMichiel Vlaming, Eveline M A Bleiker, Gina Schijven, et al.
Gastroenterology|October 22, 2021
Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk IndividualsKasper A Overbeek, Michael G Goggins, Mohamad Dbouk, et al.
Maturitas|April 22, 2025
No increased arterial stiffness after premenopausal risk-reducing salpingo-oophorectomy (RRSO)Maarten J Beekman, Lara Terra, Jeanine E Roeters van Lennep, et al.
Gynecologic Oncology|May 25, 2024
Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriersIris A S Stroot, Joost Bart, Harry Hollema, et al.
Journal of the National Cancer Institute|June 27, 2023
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiationMark van Barele, Delal Akdeniz, Bernadette A M Heemskerk-Gerritsen, et al.
Maturitas|February 22, 2026
Long-term outcomes of surgical menopause after risk-reducing salpingo-oophorectomy: results of the HARMOny studyMaarten J Beekman, Lara Terra, Eveline M A Bleiker, et al.
Human Mutation|May 10, 2006
A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic settingAnnemarie H van der Hout, Ans M W van den Ouweland, Rob B van der Luijt, et al.
Pageof 21

Showing results (161-170 of 204) with videos related to

Sort By:
Pageof 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2023
High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of <i>BRCA1/2</i> Pathogenic Variants: Prevalence and Clinical FactorsIris A S Stroot, Jan Brouwer, Joost Bart, et al.
Journal of Medical Genetics|September 6, 2005
Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP)M Nielsen, P F Franken, T H C M Reinards, et al.
British Journal of Cancer|January 16, 2014
Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trialM R Wevers, N K Aaronson, S Verhoef, et al.
International Journal of Cancer|October 13, 2025
Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathwayMichiel Vlaming, Eveline M A Bleiker, Gina Schijven, et al.
Gastroenterology|October 22, 2021
Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk IndividualsKasper A Overbeek, Michael G Goggins, Mohamad Dbouk, et al.
Maturitas|April 22, 2025
No increased arterial stiffness after premenopausal risk-reducing salpingo-oophorectomy (RRSO)Maarten J Beekman, Lara Terra, Jeanine E Roeters van Lennep, et al.
Gynecologic Oncology|May 25, 2024
Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriersIris A S Stroot, Joost Bart, Harry Hollema, et al.
Journal of the National Cancer Institute|June 27, 2023
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiationMark van Barele, Delal Akdeniz, Bernadette A M Heemskerk-Gerritsen, et al.
Maturitas|February 22, 2026
Long-term outcomes of surgical menopause after risk-reducing salpingo-oophorectomy: results of the HARMOny studyMaarten J Beekman, Lara Terra, Eveline M A Bleiker, et al.
Human Mutation|May 10, 2006
A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic settingAnnemarie H van der Hout, Ans M W van den Ouweland, Rob B van der Luijt, et al.
Pageof 21